No Data
Asian Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
Asian equities traded in the US as American depositary receipts were higher in Wednesday trading, rising 1.04% to 2,008.61 on the S&P Asia 50 ADR Index. From North Asia, the gainers were led by live g
Asian Equities Traded in the US as American Depositary Receipts Open Week on Flat Note
Asian equities traded in the US as American depositary receipts started the week flat Monday morning, nudging 0.005% higher to 1,959.42 on the S&P Asia 50 ADR Index. From North Asia, the gainers were
Dr. Reddy's to Co-market Zydus' Breast Cancer Treatment in India
Dr. Reddy's Laboratories (RDY) plans to co-market Zydus Lifesciences' Pertuzumab biosimilar to treat breast cancer patients in India. Zydus will market the product under the Sigrima brand name while D
Dr. Reddy's Laboratories Shares Are Trading Higher After the Company Announced It Signed a Definitive Agreement With Haleon for Purchase of Shares of Northstar Switzerland SARL to Acquire Its Global Portfolio of Consumer Healthcare Brands in the...
Dr. Reddy's Laboratories Shares Are Trading Higher After the Company Announced It Signed a Definitive Agreement With Haleon for Purchase of Shares of Northstar Switzerland SARL to Acquire Its Global P
Asian Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading
Asian equities traded in the US as American depositary receipts were flat in late Thursday morning trading, nudging 0.04% higher to 1,957.15 on the S&P Asia 50 ADR Index. From North Asia, the gainers
Dr. Reddy's to Acquire Haleon's Nicotine Replacement Therapy Business Outside US
Dr. Reddy's Laboratories (NSE:DRREDDY, BOM:500124), through its Swiss arm, agreed to acquire British consumer healthcare company Haleon's nicotine replacement therapy business outside the US, accordin